Discover
SKYE
Skye Bioscience, Inc.
1.69
2 x 1.16
4 x 1.83
bid
ask
+
0.01
0.60%
3 @ 04:00 PM
1.69 +0.00 (0.00%)
| Ytd | -71.83% | |
| 1y | -87.72% |
1.68
day range
1.76
1.57
52 week range
13.84
| Open | 1.69 | Prev Close | 1.68 | Low | 1.68 | High | 1.76 | Mkt Cap | 7.48M |
| Vol | 18.67K | Avg Vol | 89.28K | EPS | -10.16 | P/E | N/A | Forward P/E | -2.27 |
| Beta | 1.75 | Short Ratio | 10.06 | Inst. Own | 86.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 2.50 | 200-d Avg | 5.32 | 1yr Est | 18.00 |
| Income Statement | |||
| Operating Expenses | 11.06M | ||
| Research and Development Expense | 3.94M | ||
| Selling, General and Administrative Expense | 3.87M | ||
| Operating Income | -11.06M | ||
| Interest Expense | 3.30K | ||
| Income Tax Expense | 3.40K | ||
| Net Income | -10.79M | ||
| Net Income Common Stock | -10.79M | ||
| Net Income Common Stock (USD) | -10.79M | ||
| Consolidated Income | -10.79M | ||
| Earnings per Basic Share | -2.16 | ||
| Earnings per Basic Share (USD) | -2.16 | ||
| Earnings per Diluted Share | -2.16 | ||
| Earning Before Interest & Taxes (EBIT) | -10.78M | ||
| Earning Before Interest & Taxes (USD) | -10.78M | ||
| Weighted Average Shares | 4.96M | ||
| Weighted Average Shares Diluted | 4.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.07M | ||
| Cash and Equivalents (USD) | 8.07M | ||
| Investments | 2.00M | ||
| Investments Current | 2.00M | ||
| Current Assets | 10.96M | ||
| Property, Plant & Equipment Net | 66.60K | ||
| Total Assets | 11.03M | ||
| Debt Current | 178.75K | ||
| Total Debt | 178.75K | ||
| Current Liabilities | 11.53M | ||
| Total Liabilities | 11.53M | ||
| Accumulated Retained Earnings (Deficit) | -210.17M | ||
| Shareholders Equity | -497.31K | ||
| Shareholders Equity (USD) | -497.31K | ||
| Assets Non-Current | 74.91K | ||
| Total Debt (USD) | 178.75K | ||
| Trade and Non-Trade Payables | 4.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 157.60K | ||
| Net Cash Flow from Financing | -101.01K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -80.66K | ||
| Net Cash Flow - Business Acquisitions and Disposals | 178.20K | ||
| Issuance (Purchase) of Equity Shares | 6.27K | ||
| Issuance (Repayment) of Debt Securities | -107.29K | ||
| Net Cash Flow from Investing | 7.14M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.96M | ||
| Net Cash Flow from Operations | -7.12M | ||
| Share Based Compensation | 1.27M | ||